Pleiotropic actions of allopregnanolone underlie therapeutic benefits in stress-related disease.

Allopregnanolone CRF GABAergic transmission Pregnenolone Progesterone Toll-like receptors

Journal

Neurobiology of stress
ISSN: 2352-2895
Titre abrégé: Neurobiol Stress
Pays: United States
ID NLM: 101643409

Informations de publication

Date de publication:
May 2020
Historique:
received: 03 10 2019
revised: 15 11 2019
accepted: 21 11 2019
entrez: 28 12 2019
pubmed: 28 12 2019
medline: 28 12 2019
Statut: epublish

Résumé

For several years, research from around the world has suggested that the neuroactive steroid (3α,5α)-3-hydroxypregnan-20-one (allopregnanolone) may have therapeutic potential for treatment of various stress-related diseases including post-traumatic stress disorder (PTSD), depression, alcohol use disorders (AUDs), as well as neurological and psychiatric conditions that are worsened in the presence of stress, such as multiple sclerosis, schizophrenia, and seizure disorders. In this review, we make the argument that the pleiotropic actions of allopregnanolone account for its ability to promote recovery in such a wide variety of illnesses. Likewise, the allopregnanolone precursors, pregnenolone and progesterone, share many actions of allopregnanolone. Of course, pregnenolone and progesterone lack direct effects on GABA

Identifiants

pubmed: 31879693
doi: 10.1016/j.ynstr.2019.100203
pii: S2352-2895(19)30055-4
pii: 100203
pmc: PMC6920111
doi:

Types de publication

Journal Article

Langues

eng

Pagination

100203

Subventions

Organisme : NIAAA NIH HHS
ID : R01 AA024095
Pays : United States

Informations de copyright

© 2019 The Authors.

Déclaration de conflit d'intérêts

All other authors report no conflict of interest.

Références

Neuropharmacology. 2019 Mar 15;147:66-73
pubmed: 29630902
Brain Res. 1997 Aug 1;764(1-2):173-8
pubmed: 9295207
Eur J Pharmacol. 1987 Oct 27;142(3):483-5
pubmed: 2828079
Biol Psychiatry. 2006 Oct 1;60(7):704-13
pubmed: 16934764
Epilepsia. 2013 Sep;54 Suppl 6:93-8
pubmed: 24001085
Horm Behav. 2009 Jun;56(1):35-43
pubmed: 19269291
J Immunol. 2006 Feb 1;176(3):1869-77
pubmed: 16424218
Brain Res. 1998 Jun 15;796(1-2):222-30
pubmed: 9689472
Psychoneuroendocrinology. 2007 Sep-Nov;32(8-10):1062-78
pubmed: 17928160
J Med Chem. 1990 Jun;33(6):1572-81
pubmed: 2160534
Pain. 2007 Sep;131(1-2):142-52
pubmed: 17292548
Psychopharmacology (Berl). 2006 Jun;186(3):281-92
pubmed: 16133140
Psychopharmacology (Berl). 1987;93(2):226-9
pubmed: 3122256
Psychoneuroendocrinology. 2016 Mar;65:44-53
pubmed: 26716877
J Intern Med. 2011 Oct;270(4):319-26
pubmed: 21793950
J Neurosci. 2011 Dec 14;31(50):18198-210
pubmed: 22171026
Eur J Pharmacol. 2007 Oct 31;572(2-3):94-101
pubmed: 17658511
Prog Brain Res. 2009;175:219-37
pubmed: 19660659
Neuropsychopharmacology. 2017 Jan;42(1):156-177
pubmed: 27402494
Exp Neurol. 2008 Apr;210(2):349-58
pubmed: 18190912
Brain Res. 1991 Oct 4;561(1):157-61
pubmed: 1686744
Neuropharmacology. 2012 Dec;63(8):1315-26
pubmed: 22939998
Proc Natl Acad Sci U S A. 1998 Mar 17;95(6):3239-44
pubmed: 9501247
Nat Rev Neurosci. 2009 Jun;10(6):397-409
pubmed: 19469025
Neurosci Biobehav Rev. 2019 Sep 3;:null
pubmed: 31491473
Gynecol Endocrinol. 1995 Mar;9(1):1-7
pubmed: 7793294
Neuroscience. 2010 Feb 17;165(4):1039-51
pubmed: 19931360
Hippocampus. 2015 Mar;25(3):393-405
pubmed: 25331166
Nat Neurosci. 2017 Feb;20(2):156-166
pubmed: 28092663
Ann Emerg Med. 2007 Apr;49(4):391-402, 402.e1-2
pubmed: 17011666
Mol Psychiatry. 2010 Jun;15(6):574-88
pubmed: 20010888
Alcohol Clin Exp Res. 2008 Jan;32(1):19-26
pubmed: 18070250
Nat Neurosci. 2009 Apr;12(4):438-43
pubmed: 19252497
Brain Res. 1987 Jul 14;415(2):393-8
pubmed: 3111642
Pharmacol Biochem Behav. 2003 Feb;74(3):683-90
pubmed: 12543235
J Neuroinflammation. 2008 Mar 18;5:10
pubmed: 18348728
Pharmacol Biochem Behav. 2006 Aug;84(4):609-17
pubmed: 16996120
Exp Neurol. 2004 Oct;189(2):404-12
pubmed: 15380490
Pharmacol Ther. 2007 Oct;116(1):77-106
pubmed: 17659348
Nature. 1998 Apr 30;392(6679):926-30
pubmed: 9582073
Alcohol Clin Exp Res. 2005 Apr;29(4):528-37
pubmed: 15834217
Lancet. 2018 Sep 22;392(10152):1058-1070
pubmed: 30177236
Brain Res. 1997 Aug 1;764(1-2):158-66
pubmed: 9295205
Proc Natl Acad Sci U S A. 1991 May 15;88(10):4553-7
pubmed: 1852011
Psychoneuroendocrinology. 2011 Apr;36(3):426-36
pubmed: 21041030
J Neurosci. 2000 Mar 1;20(5):1982-9
pubmed: 10684899
Cell Physiol Biochem. 2019;53(1):1-18
pubmed: 31162913
Brain Res Dev Brain Res. 2001 Nov 26;131(1-2):31-9
pubmed: 11718833
Nat Rev Neurosci. 2005 Jul;6(7):565-75
pubmed: 15959466
J Neurosci. 2005 Mar 23;25(12):3219-28
pubmed: 15788779
Alcohol Clin Exp Res. 2010 Mar 1;34(3):432-42
pubmed: 20028362
J Biol Chem. 2019 Mar 22;294(12):4596-4607
pubmed: 30647133
Eur J Neurosci. 2004 Sep;20(6):1665-73
pubmed: 15355334
Behav Brain Res. 1999 Apr;100(1-2):207-15
pubmed: 10212068
J Pharmacol Exp Ther. 1997 Sep;282(3):1213-8
pubmed: 9316828
Neuropsychopharmacology. 2019 Jan;44(2):364-371
pubmed: 29760410
J Neurosci. 2005 Aug 24;25(34):7724-33
pubmed: 16120773
Int Breastfeed J. 2007 Mar 30;2:6
pubmed: 17397549
J Neuroinflammation. 2010 Aug 02;7:43
pubmed: 20678226
Brain Res. 1992 Feb 28;573(2):353-5
pubmed: 1504771
Nat Rev Neurosci. 2005 Jun;6(6):463-75
pubmed: 15891777
Curr Top Behav Neurosci. 2014;18:13-24
pubmed: 24652609
Mol Pharmacol. 2004 May;65(5):1191-7
pubmed: 15102947
Steroids. 1982 Mar;39(3):259-78
pubmed: 7090024
Eur J Neurosci. 2000 Jul;12(7):2639-43
pubmed: 10947838
Pain. 2008 Aug 31;138(2):402-9
pubmed: 18343034
Pharmacol Biochem Behav. 2002 Mar;71(3):457-68
pubmed: 11830180
Epilepsy Res. 2015 Jan;109:13-27
pubmed: 25524838
Pharmacol Biochem Behav. 2000 Sep;67(1):137-43
pubmed: 11113493
Brain Res. 1998 Oct 5;807(1-2):91-100
pubmed: 9757006
Sleep Med Clin. 2015 Mar;10(1):1-10
pubmed: 26055668
Neuron. 1990 May;4(5):759-65
pubmed: 2160838
J Neurochem. 2003 Apr;85(1):257-63
pubmed: 12641747
Neuroscience. 2016 Apr 21;320:172-82
pubmed: 26868968
J Pharmacol Exp Ther. 1994 Sep;270(3):1223-9
pubmed: 7932175
Psychoneuroendocrinology. 2013 Sep;38(9):1532-44
pubmed: 23374328
J Neurosci. 2013 Dec 11;33(50):19534-54
pubmed: 24336719
Neuropharmacology. 2018 May 1;133:242-253
pubmed: 29407214
Pharmacol Biochem Behav. 2004 Jul;78(3):495-504
pubmed: 15251258
Front Neuroendocrinol. 2014 Apr;35(2):234-44
pubmed: 24456850
Psychopharmacology (Berl). 2017 Jan;234(1):79-88
pubmed: 27665607
Ann Clin Transl Neurol. 2017 Apr 26;4(6):411-414
pubmed: 28589168
Nat Rev Endocrinol. 2013 Apr;9(4):241-50
pubmed: 23438839
Alcohol. 2016 May;52:9-23
pubmed: 27139233
Mol Pharmacol. 1990 Feb;37(2):263-70
pubmed: 1689453
Proc Natl Acad Sci U S A. 2006 Oct 10;103(41):15230-5
pubmed: 17005728
Eur J Pharmacol. 2004 Dec 15;506(2):129-32
pubmed: 15588732
Proc Natl Acad Sci U S A. 1996 Oct 29;93(22):12599-604
pubmed: 8901628
Arch Gen Psychiatry. 2007 Feb;64(2):193-200
pubmed: 17283286
Psychopharmacology (Berl). 2014 Sep;231(17):3437-44
pubmed: 24658404
Psychoneuroendocrinology. 2012 Apr;37(4):543-53
pubmed: 21890277
Brain Res. 1998 Oct 5;807(1-2):84-90
pubmed: 9757004
Brain Res. 1993 Oct 1;623(2):229-34
pubmed: 8221104
Endocrinology. 2001 Nov;142(11):4617-22
pubmed: 11606426
Am J Psychiatry. 1997 May;154(5):624-9
pubmed: 9137116
J Neurosci. 2013 Oct 2;33(40):15879-93
pubmed: 24089494
J Neurosci. 2008 Mar 5;28(10):2527-38
pubmed: 18322097
Neurosci Biobehav Rev. 2016 Apr;63:143-57
pubmed: 26872620
Front Neuroendocrinol. 2015 Jan;36:28-48
pubmed: 24929099
Alcohol Clin Exp Res. 1995 Apr;19(2):350-5
pubmed: 7625568
Stress. 2005 Dec;8(4):259-64
pubmed: 16423714
Cerebellum. 2013 Jun;12(3):307-9
pubmed: 23315008
J Neurochem. 2006 Jul;98(1):122-33
pubmed: 16805802
Arch Gen Psychiatry. 2004 Jul;61(7):705-13
pubmed: 15237082
Mol Psychiatry. 2011 Apr;16(4):383-406
pubmed: 21079608
Endocrinology. 2000 Dec;141(12):4801-4
pubmed: 11108297
Sci Rep. 2019 Feb 4;9(1):1220
pubmed: 30718548
Neuropsychopharmacology. 2009 Jul;34(8):1885-903
pubmed: 19339966
Pain Med. 2016 Jan;17(1):25-32
pubmed: 26176345
Front Cell Neurosci. 2014 Jun 03;8:134
pubmed: 24917787
PLoS One. 2011;6(6):e20719
pubmed: 21673960
Alcohol Clin Exp Res. 2013 Dec;37(12):2086-97
pubmed: 23895427
J Neurochem. 1993 Jun;60(6):2212-6
pubmed: 8388035
Ann Neurol. 2014 Dec;76(6):911-5
pubmed: 25363147
J Neurophysiol. 1995 Jul;74(1):464-9
pubmed: 7472348
Transl Psychiatry. 2016 Oct 4;6(10):e910
pubmed: 27701406
Neuropharmacology. 2017 Feb;113(Pt A):314-322
pubmed: 27743930
Brain Sci. 2016 Jul 27;6(3):null
pubmed: 27472367
Neuroscience. 2012 Jul 26;215:114-26
pubmed: 22542673
Restor Neurol Neurosci. 2004;22(1):19-31
pubmed: 15096691
CNS Neurol Disord Drug Targets. 2007 Apr;6(2):127-40
pubmed: 17430150
Nat Rev Neurosci. 2016 Oct;17(10):636-51
pubmed: 27586075
Neural Plast. 2012;2012:261345
pubmed: 22530155
Nature. 2006 Nov 23;444(7118):486-9
pubmed: 17108970
Nat Rev Neurosci. 2008 Jan;9(1):46-56
pubmed: 18073775
J Pharmacol Exp Ther. 1996 Aug;278(2):510-7
pubmed: 8768698
Neuropharmacology. 2004 Mar;46(4):570-9
pubmed: 14975681
J Neuroinflammation. 2017 Jan 25;14(1):22
pubmed: 28118842
Steroids. 2009 Apr-May;74(4-5):463-73
pubmed: 19171160
Curr Opin Pharmacol. 2002 Feb;2(1):23-33
pubmed: 11786305
Sci Am. 1998 Jun;278(6):42-9
pubmed: 9608732
Alcohol Clin Exp Res. 2005 Jul;29(7):1351-5
pubmed: 16088999
Trends Neurosci. 1991 Dec;14(12):515-9
pubmed: 1726341
J Neurophysiol. 2003 Aug;90(2):903-10
pubmed: 12702713
Eur J Neurosci. 2009 May;29(9):1779-94
pubmed: 19473233
Psychopharmacology (Berl). 2006 May;186(1):122-32
pubmed: 16568282
Pharmacol Ther. 2007 Oct;116(1):20-34
pubmed: 17531325
Nature. 2012 Oct 18;490(7420):402-6
pubmed: 22992525
Brain Res Rev. 2008 Mar;57(2):520-30
pubmed: 17920688
Pharmacol Ther. 2007 Oct;116(1):1-6
pubmed: 17531324
Neuropsychopharmacology. 2000 Mar;22(3):219-29
pubmed: 10693149
Psychopharmacology (Berl). 2013 Nov;230(2):151-88
pubmed: 24071826
J Neurosci. 2008 Oct 29;28(44):11391-400
pubmed: 18971481
Neuropsychopharmacology. 2007 Feb;32(2):471-82
pubmed: 17063153
J Cell Mol Med. 2019 Oct;23(10):7021-7028
pubmed: 31430030
Biol Res Nurs. 2008 Oct;10(2):128-33
pubmed: 18829596
Neuropsychopharmacology. 2003 Jul;28(7):1328-35
pubmed: 12784115
Cell Mol Neurobiol. 2019 May;39(4):523-537
pubmed: 30187261
Brain Res Mol Brain Res. 1995 Dec 1;34(1):29-37
pubmed: 8750858
Pharmacol Ther. 2007 Oct;116(1):125-39
pubmed: 17597217
Mol Pharmacol. 1991 Jun;39(6):691-6
pubmed: 1646944
Neuropharmacology. 2017 Aug 1;122:56-73
pubmed: 28159648
Nat Neurosci. 2014 Dec;17(12):1751-8
pubmed: 25402857
Proc Natl Acad Sci U S A. 2001 Feb 27;98(5):2849-54
pubmed: 11226329
Brain Struct Funct. 2008 Sep;213(1-2):63-72
pubmed: 18696110
Receptors Channels. 1993;1(2):135-42
pubmed: 8081717
Brain Res. 1986 Nov 29;398(2):382-5
pubmed: 2879610
Prog Neurobiol. 2014 Feb;113:79-87
pubmed: 24215796
Nat Rev Drug Discov. 2010 Apr;9(4):293-307
pubmed: 20380038
J Neurosci. 2002 May 1;22(9):3795-805
pubmed: 11978855
J Neuroimmunol. 2008 Feb;194(1-2):115-22
pubmed: 18192029
Pharmacol Ther. 2007 Oct;116(1):140-71
pubmed: 17555824
Proc Natl Acad Sci U S A. 2003 Nov 25;100(24):14439-44
pubmed: 14623958
PLoS One. 2011;6(8):e14829
pubmed: 21829592
Neurosci Lett. 2017 May 10;649:156-163
pubmed: 28215878
Neuroscience. 1994 Sep;62(1):265-71
pubmed: 7816204
J Neurosci. 2007 Feb 28;27(9):2155-62
pubmed: 17329412
PLoS One. 2009 Aug 11;4(8):e6585
pubmed: 19668376
Brain Res. 1989 May 15;487(1):45-51
pubmed: 2546650
Am J Psychiatry. 1998 Jul;155(7):910-3
pubmed: 9659856
Psychopharmacology (Berl). 2016 Apr;233(7):1299-310
pubmed: 26856852
J Neurochem. 2000 Aug;75(2):732-40
pubmed: 10899949
Proc Natl Acad Sci U S A. 1999 Oct 26;96(22):12905-10
pubmed: 10536021
J Neurosci. 2002 May 1;22(9):3366-75
pubmed: 11978813
Psychopharmacology (Berl). 2016 May;233(9):1623-36
pubmed: 26803500
Front Cell Neurosci. 2018 Jun 20;12:148
pubmed: 29973870
Mediators Inflamm. 2013;2013:893521
pubmed: 23935250
Proc Natl Acad Sci U S A. 1999 Nov 9;96(23):13512-7
pubmed: 10557352
Psychoneuroendocrinology. 2014 Mar;41:75-88
pubmed: 24495609
Neuropharmacology. 2002 Sep;43(4):651-61
pubmed: 12367610
Neurosci Biobehav Rev. 2011 Jan;35(3):818-25
pubmed: 20946914
Alcohol Clin Exp Res. 2017 Dec;41(12):2066-2081
pubmed: 28941277
Alcohol Clin Exp Res. 2005 Apr;29(4):517-27
pubmed: 15834216
Psychopharmacology (Berl). 2017 May;234(9-10):1483-1498
pubmed: 28210782
Lancet. 2017 Jul 29;390(10093):480-489
pubmed: 28619476
Epilepsia. 2018 Oct;59 Suppl 2:220-227
pubmed: 29453777

Auteurs

Giorgia Boero (G)

Department of Psychiatry, Department of Pharmacology, Bowles Center for Alcohol Studies, University of North Carolina at Chapel Hill, School of Medicine, Chapel Hill, NC, 27599, USA.

Patrizia Porcu (P)

Neuroscience Institute, National Research Council of Italy (CNR), Cagliari, Italy.

A Leslie Morrow (AL)

Department of Psychiatry, Department of Pharmacology, Bowles Center for Alcohol Studies, University of North Carolina at Chapel Hill, School of Medicine, Chapel Hill, NC, 27599, USA.

Classifications MeSH